Deletion mutants of VPg reveal new cytopathology determinants in a picornavirus

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Arias, Armando ^a,c   Perales, Celia ^a,b   Escarmís, Cristina ^a   Domingo, Esteban ^a,b  

^a CSIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 2C; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 3A; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; VPG PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; CYTOPATHOLOGY; DELETION MUTANT; FOOT AND MOUTH DISEASE VIRUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS PLAQUE; VIRUS REPLICATION; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; CYTOPATHOGENIC EFFECT; GENE DELETION; GENE DOSAGE; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PHENOTYPE; PHYSIOLOGY; PICORNAVIRUS;

FOOT-AND-MOUTH DISEASE VIRUS; PICORNAVIRIDAE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; FOOT-AND-MOUTH DISEASE VIRUS; GENE DELETION; GENE DOSAGE; GENOME, VIRAL; MOLECULAR SEQUENCE DATA; PHENOTYPE; PICORNAVIRIDAE; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 77956297517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010735     Document Type: Article

References (66)

1. Lewin B (2007) Genes. Sudbury Massachusetts: Jones & Bartlett Publishers Inc.
2. Ball LA (2007) Virus replication strategies. In: Knipe DM, Howley PM, eds. Fields Virology, 5th ed Philadelphia: LWW. pp 119-140.
3. Ferrer-Orta C, Arias A, Agudo R, Perez-Luque R, Escarmis C, et al. (2006) The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J 25: 880-888.
4. Kamtekar S, Berman AJ, Wang J, Lazaro JM, de Vega M, et al. (2006) The phi29 DNA polymerase:protein-primer structure suggests a model for the initiation to elongation transition. EMBO J 25: 1335-1343.
5. Salas M (1991) Protein-priming of DNA replication. Annu Rev Biochem 60: 39-71.
6. Paul AV (2002) Possible unifying mechanism of picornavirus genome replication; Semler BL, ed, Wimmer E. Washington DC: ASM Press. pp 227-246.
7. Paul AV, van Boom JH, Filippov D, Wimmer E (1998) Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature 393: 280-284.
8. Forss S, Schaller H (1982) A tandem repeat gene in a picornavirus. Nucleic Acids Res 10: 6441-6450.
9. King AM, Sangar DV, Harris TJ, Brown F (1980) Heterogeneity of the genomelinked protein of foot-and-mouth disease virus. J Virol 34: 627-634.
10. Nayak A, Goodfellow IG, Belsham GJ (2005) Factors required for the Uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol 79: 7698-7706.
11. Falk MM, Sobrino F, Beck E (1992) VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol 66: 2251-2260.
12. Pacheco JM, Henry TM, O'Donnell VK, Gregory JB, Mason PW (2003) Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-andmouth disease virus. J Virol 77: 13017-13027.
13. Cao X, Kuhn RJ, Wimmer E (1993) Replication of poliovirus RNA containing two VPg coding sequences leads to a specific deletion event. J Virol 67: 5572-5578.
14. Cao X, Wimmer E (1996) Genetic variation of the poliovirus genome with two VPg coding units. EMBO J 15: 23-33.
15. Ryan MD, Donnelly MLL, Flint M, Cowton VM, Luke G, et al. (2004) Footand- mouth disease virus proteinases. In: Sobrino F, Domingo E, eds. Foot-andmouth disease: current perspectives. Wymondham, UK: Horizon Bioscience. pp 53-76.
16. Nayak A, Goodfellow IG, Woolaway KE, Birtley J, Curry S, et al. (2006) Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication. J Virol 80: 9865-9875.
17. Marcotte LL, Wass AB, Gohara DW, Pathak HB, Arnold JJ, et al. (2007) Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase. J Virol 81: 3583-3596.
18. Paul AV, Peters J, Mugavero J, Yin J, van Boom JH, et al. (2003) Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J Virol 77: 891-904.
19. Tellez AB, Crowder S, Spagnolo JF, Thompson AA, Peersen OB, et al. (2006) Nucleotide channel of RNA-dependent RNA polymerase used for intermolecular uridylylation of protein primer. J Mol Biol 357: 665-675.
20. Rodriguez PL, Carrasco L (1993) Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem 268: 8105-8110.
21. Rodriguez PL, Carrasco L (1995) Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem 270: 10105-10112.
22. Banerjee R, Echeverri A, Dasgupta A (1997) Poliovirus-encoded 2C polypeptide specifically binds to the 39-terminal sequences of viral negative-strand RNA. J Virol 71: 9570-9578.
23. Mirzayan C, Wimmer E (1994) Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity. Virology 199: 176-187.
24. Steil BP, Barton DJ (2009) Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Res 139: 240-252.
25. Vance LM, Moscufo N, Chow M, Heinz BA (1997) Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 71: 8759-8765.
26. Li JP, Baltimore D (1990) An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J Virol 64: 1102-1107.
27. Cho MW, Teterina N, Egger D, Bienz K, Ehrenfeld E (1994) Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202: 129-145.
28. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E (1997) Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol 71: 8962-8972.
29. Bienz K, Egger D, Pasamontes L (1987) Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology 160: 220-226.
30. Schlegel A, Giddings TH, Jr., Ladinsky MS, Kirkegaard K (1996) Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol 70: 6576-6588.
31. Suhy DA, Giddings TH, Jr., Kirkegaard K (2000) Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagylike origin for virus-induced vesicles. J Virol 74: 8953-8965.
32. Teterina NL, Rinaudo MS, Ehrenfeld E (2003) Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A. J Virol 77: 12679-12691.
33. Yin J, Liu Y, Wimmer E, Paul AV (2007) Complete protein linkage map between the P2 and P3 non-structural proteins of poliovirus. J Gen Virol 88: 2259-2267.
34. Xiang W, Cuconati A, Hope D, Kirkegaard K, Wimmer E (1998) Complete protein linkage map of poliovirus P3 proteins: interaction of polymerase 3Dpol with VPg and with genetic variants of 3AB. J Virol 72: 6732-6741.
35. Lyle JM, Bullitt E, Bienz K, Kirkegaard K (2002) Visualization and functional analysis of RNA-dependent RNA polymerase lattices. Science 296: 2218-2222.
36. Garcia-Briones M, Rosas MF, Gonzalez-Magaldi M, Martin-Acebes MA, Sobrino F, et al. (2006) Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells. Virology 349: 409-421.
37. Monaghan P, Cook H, Jackson T, Ryan M, Wileman T (2004) The ultrastructure of the developing replication site in foot-and-mouth disease virus-infected BHK-38 cells. J Gen Virol 85: 933-946.
38. Verdaguer N, Fita I, Domingo E, Mateu MG (1997) Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding. J Virol 71: 9813-9816.
39. Perales C, Agudo R, Domingo E (2009) Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. PLoS One 4: e5554.
40. Herrera M, Garcia-Arriaza J, Pariente N, Escarmis C, Domingo E (2007) Molecular basis for a lack of correlation between viral fitness and cell killing capacity. PLoS Pathog 3: e53.
41. Garcia-Arriaza J, Manrubia SC, Toja M, Domingo E, Escarmis C (2004) Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol 78: 11678-11685.
42. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, et al. (2005) Comparative genomics of foot-and-mouth disease virus. J Virol 79: 6487-6504.
43. Yin J, Paul AV, Wimmer E, Rieder E (2003) Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of single- and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J Virol 77: 5152-5166.
44. Domingo E, Escarmís C, Menéndez-Arias L, Perales C, Herrera M, et al. (2008) Viral quasispecies: dynamics, interactions and pathogenesis. In: Domingo E, Parrish C, Holland JJ, eds. Origin and Evolution of Viruses, 2nd ed Oxford, UK: Elsevier. pp 87-118.
45. Grubman MJ, Moraes MP, Diaz-San Segundo F, Pena L, de los Santos T (2008) Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol Med Microbiol 53: 8-17.
46. Sierra S, Davila M, Lowenstein PR, Domingo E (2000) Response of foot-andmouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol 74: 8316-8323.
47. Belsham GJ, Normann P (2008) Dynamics of picornavirus RNA replication within infected cells. J Gen Virol 89: 485-493.
48. Pariente N, Airaksinen A, Domingo E (2003) Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J Virol 77: 7131-7138.
49. Baranowski E, Sevilla N, Verdaguer N, Ruiz-Jarabo CM, Beck E, et al. (1998) Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol 72: 6362-6372.
50. Martinez-Salas E, Saiz JC, Davila M, Belsham GJ, Domingo E (1993) A single nucleotide substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to enhanced cap-independent translation in vivo. J Virol 67: 3748-3755.
51. Escarmis C, Perales C, Domingo E (2009) Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing. J Virol 83: 6748-6756.
52. Ferrer-Orta C, Arias A, Escarmis C, Verdaguer N (2006) A comparison of viral RNA-dependent RNA polymerases. Curr Opin Struct Biol 16: 27-34.
53. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, et al. (2004) A mouseadapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78: 7916-7924.
54. Harris JR, Racaniello VR (2003) Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J Virol 77: 4773-4780.
55. Harris JR, Racaniello VR (2005) Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J Virol 79: 5363-5373.
56. Sanz-Ramos M, Diaz-San Segundo F, Escarmis C, Domingo E, Sevilla N (2008) Hidden virulence determinants in a viral quasispecies in vivo. J Virol 82: 10465-10476.
57. Nuñez JI, Baranowski E, Molina N, Ruiz-Jarabo CM, Sanchez C, et al. (2001) A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol 75: 3977-3983.
58. Toja M, Escarmis C, Domingo E (1999) Genomic nucleotide sequence of a footand- mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res 64: 161-171.
59. Escarmis C, Davila M, Charpentier N, Bracho A, Moya A, et al. (1996) Genetic lesions associated with Muller's ratchet in an RNA virus. J Mol Biol 264: 255-267.
60. Arias A, Agudo R, Ferrer-Orta C, Perez-Luque R, Airaksinen A, et al. (2005) Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. J Mol Biol 353: 1021-1032.
61. Sierra M, Airaksinen A, Gonzalez-Lopez C, Agudo R, Arias A, et al. (2007) Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J Virol 81: 2012-2024.
62. Perales C, Mateo R, Mateu MG, Domingo E (2007) Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants. J Mol Biol 369: 985-1000.
63. Arias A, Ruiz-Jarabo CM, Escarmis C, Domingo E (2004) Fitness increase of memory genomes in a viral quasispecies. J Mol Biol 339: 405-412.
64. Cline J, Braman JC, Hogrefe HH (1996) PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res 24: 3546-3551.
65. Arias A, Lazaro E, Escarmis C, Domingo E (2001) Molecular intermediates of fitness gain of an RNA virus: characterization of a mutant spectrum by biological and molecular cloning. J Gen Virol 82: 1049-1060.
66. Perales C, Agudo R, Tejero H, Manrubia SC, Domingo E (2009) Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. PLoS Pathog 5: e1000658.